SCHEMBL3566904

SCHEMBL3566904

CC(NC(=O)C(F)c1ccc2cc(C(=O)O)sc2c1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.46
HDAC1 Q13547 7/20 0.42
HDAC3 O15379 3/20 0.42
HDAC4 P56524 3/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC6 Q9UBN7 3/20 0.41
KEAP1 Q14145 2/20 0.41
NFE2L2 Q16236 2/20 0.41
POLB P06746 2/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3566907 1.00 BCL2L1 (0.46) BCL2L1HDAC1HDAC3HDAC4MEN1
SCHEMBL3574131 0.91 ALDH1A1 (0.41) BCL2L1ALDH1A1
SCHEMBL3568970 0.91 ALDH1A1 (0.41) BCL2L1ALDH1A1
SCHEMBL3568972 0.91 ALDH1A1 (0.41) BCL2L1ALDH1A1
SCHEMBL3566027 0.86 BCL2L1 (0.46) BCL2L1HDAC1HDAC3HDAC4HDAC6
SCHEMBL3573993 0.83 BCL2L1 (0.45) BCL2L1HDAC1HDAC3HDAC4HDAC6
SCHEMBL3562088 0.82 BCL2L1 (0.49) BCL2L1HDAC1POLBRAB9A
SCHEMBL3574611 0.79 HDAC1 (0.52) BCL2L1HDAC1
SCHEMBL3571329 0.76 BCL2L1 (0.49) BCL2L1HDAC1HDAC3HDAC4HDAC6
SCHEMBL3569538 0.74 PRSS12 (0.47) BCL2L1HDAC1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834034-B2 Benzothiophene derivatives MERCK SHARP & DOHME CORP. (US) 2010-11-16 US claimed
US-20090012075-A1 Fluorinated Arylamide Derivatives MERCK SHARP & DOHME CORP. 2009-01-08 US claimed
EP-1976511-A2 FLUORINATED ARYLAMIDE DERIVATIVES Merck & Co., Inc. (US) 2008-10-08 EP claimed
WO-2007087129-A2 FLUORINATED ARYLAMIDE DERIVATIVES MERCK & CO., INC. (US) 2007-08-02 WO claimed
US-7834034-B2 Benzothiophene derivatives MERCK SHARP & DOHME CORP. (US) 2010-11-16 US disclosed
EP-1874295-A4 BENZOTHIOPHENE DERIVATIVES MERCK & CO INC (US) 2009-08-12 EP disclosed
US-20090082308-A1 Benzothiophene derivatives MERCK SHARP & DOHME LLC 2009-03-26 US disclosed
US-20090012075-A1 Fluorinated Arylamide Derivatives MERCK SHARP & DOHME CORP. 2009-01-08 US disclosed
EP-1874295-A1 BENZOTHIOPHENE DERIVATIVES Merck & Co., Inc. (US) 2008-01-09 EP disclosed
WO-2006115845-A1 BENZOTHIOPHENE DERIVATIVES MERCK & CO., INC. (US) 2006-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012075-A1 Fluorinated Arylamide Derivatives HDAC5, AADAC, HDAC6 BCL2L1 352/4885HDAC1 4/4885HDAC3 6/4885
US-20090082308-A1 Benzothiophene derivatives BRDT, HDAC5, BRPF3 BCL2L1 156/4885HDAC1 4/4885HDAC3 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.